ArticleOPEN ACCESS

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Blood
DOI: 10.1182/blood.2022015832
33Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Zeidan, A. M., Fenaux, P., Gobbi, M., Mayer, J., Roboz, G. J., Krauter, J., … Döhner, H. (2022, July 21). Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy. Blood. Elsevier B.V. https://doi.org/10.1182/blood.2022015832

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free